BCRX
NASDAQ · Biotechnology
Biocryst Pharmaceuticals Inc
$9.31
+0.17 (+1.86%)
Open$9.18
Previous Close$9.14
Day High$9.50
Day Low$9.10
52W High$10.32
52W Low$6.00
Volume—
Avg Volume4.13M
Market Cap2.28B
P/E Ratio—
EPS$-1.78
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+610.2% upside
Current
$9.31
$9.31
Target
$66.12
$66.12
$46.17
$66.12 avg
$78.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.05B | 711.05M | 328.14M |
| Net Income | 317.05M | 193.02M | -56,674,354 |
| Profit Margin | 30.2% | 28.7% | -17.3% |
| EBITDA | 390.56M | 250.99M | -75,730,538 |
| Free Cash Flow | — | — | -52,199,092 |
| Rev Growth | +47.8% | +47.8% | +7.1% |
| Debt/Equity | 2.09 | 2.09 | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |